오스코텍

039200KOSDAQView the 제약 sectorTheme Bio & healthcare

37,500KRWMarket close of 10/22 (Thu)

Down -0.79%-300KRWMarket close of 10/22 (Thu)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/23 (Fri)37,250KRWDown -0.67%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
37,550
High
38,500
Low
36,850
Day range
Day range low 36,850 high 38,500, open 37,550, close 37,500, previous close 37,800
Volume
11×10K shares
4.0B KRW 0.80× the 20-session average

Market close of 10/22 (Thu)

Where it sits in the 1-year range

1-year close range 28,000 to 62,000 won, 28% up from the low

28% of the way up from the lowest close in 1 year (252 sessions) · -39.5% from the high

Usual range

Nothing unusual in the 6 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Daily moveusual range-0.79%-0.79%, 0.3× the usual (20-session average ±3.15%)
    That day -0.79% · usual ±3.15% · large-move threshold ±6.3%
  • Trading valueusual range0.8×4.0B KRW, 0.8× the 20-session average
    0.80× the 20-session average · check threshold 3×
  • Earningsusual range89.7B KRWOperating income over the last four quarters 89.7B KRWOperating income, 8 quarters

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+3.2B KRWusual range
  • Data date10/22 (Thu)Market close
See the full check report

Same sector · 제약

Down -2.95%

· 13 of 168 stocks up, preferred shares excluded · trading value 587.7B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions -2.6%Down -3.95%104.4B KRW
셀트리온Close over the last 20 sessions +8.3%Down -1.67%101.7B KRW
지투지바이오Close over the last 20 sessions +29.2%Down -2.14%29.6B KRW
유한양행Close over the last 20 sessions +10.7%Down -3.00%28.7B KRW
한미약품Close over the last 20 sessions -26.3%Down -2.37%28.4B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 23 days
  • Next data 10/26 (Mon) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.